Antigen-specific immunotherapy for autoimmune diseases (Q36739772)

16 August 2017

1 reference

title

Antigen-specific immunotherapy for autoimmune diseases (English)

1 reference

16 August 2017

1 reference

Kazuhiko Yamamoto

1

1 reference

16 August 2017

Akiko Okamoto

series ordinal

2

1 reference

16 August 2017

Keishi Fujio

series ordinal

3

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 March 2007

1 reference

Expert Opinion on Biological Therapy

16 August 2017

1 reference

16 August 2017

7

1 reference

16 August 2017

3

1 reference

16 August 2017

359-367

1 reference

Epidemiology and estimated population burden of selected autoimmune diseases in the United States

16 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

Safety evaluation of recombinant human interleukin-4. I. Preclinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

New drugs for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

Skin cancers after organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

A controlled trial of natalizumab for relapsing multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

Following the development of a CD4 T cell response in vivo: from activation to memory formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis: evidence for a pathogenetic role of B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

The complement system as a therapeutic target in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

Novel therapeutic strategies based on toll-like receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

Specific antigen vaccination to treat autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

Peptide-based immunotherapy of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

DNA-based immunotherapy to treat atopic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

Dendritic cell subsets and type I diabetes: focus upon DC-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

Dendritic cells as promoters of transplant tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

Dendritic cell immunotherapy: mapping the way.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

Therapeutic vaccination using CD4+CD25+ antigen-specific regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

Epitope spreading in immune-mediated diseases: implications for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

Accumulation of multiple T cell clonotypes in the synovial lesions of patients with rheumatoid arthritis revealed by a novel clonality analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

T cells accumulating in the inflamed joints of a spontaneous murine model of rheumatoid arthritis become restricted to common clonotypes during disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

Identification of systemically expanded activated T cell clones in MRL/lpr and NZB/W F1 lupus model mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

The central residues of a T cell receptor sequence motif are key determinants of autoantigen recognition in murine experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

Conserved T cell receptor usage in primary and recall responses to an immunodominant influenza virus nucleoprotein epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

A large number of T lymphocytes recognize Moloney-murine leukemia virus-induced antigens, but a few mediate long-lasting tumor immunosurveillance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

Functional reconstitution of class II MHC-restricted T cell immunity mediated by retroviral transfer of the alpha beta TCR complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

Nucleosomal peptide epitopes for nephritis-inducing T helper cells of murine lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

Gene therapy of arthritis with TCR isolated from the inflamed paw.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

Reconstitution of CD8+ T cells by retroviral transfer of the TCR alpha beta-chain genes isolated from a clonally expanded P815-infiltrating lymphocyte.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

Cancer regression in patients after transfer of genetically engineered lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

Induction of peripheral CD8+ T-cell tolerance by cross-presentation of self antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

Limited clonality in autoimmunity: drivers and regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

Progression of autoimmune diabetes driven by avidity maturation of a T-cell population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.3.359

21 January 2018

Identifiers

DOI

10.1517/14712598.7.3.359

1 reference

16 August 2017

1 reference